Background: Cholinergic urticaria (CholU) is a subset of chronic inducible urticaria characterized by the recurrent pinpoint-sized wheals that are induced by exercising or increasing core body temperature. Currently, the data of CholU in tropical climate is still limited.
Objective: To investigate the clinical features and natural course of CholU in a tropical country.
Materials And Methods: This retrospective chart review study analyzed the data of CholU patients aged over 18 years who visited Siriraj Urticaria Clinic, Siriraj Hospital, Bangkok, Thailand, between January 2007 and September 2019. Demographic data, clinical presentations, and results of provocation tests and other laboratory investigations were evaluated and compared with other studies reported in temperate zones.
Results: Sixteen out of 2,175 chronic urticaria patients (0.7%) were diagnosed with CholU. The median age of CholU patients was 28.0 ± 11.7 years with male predominance (56.3%). Three patients (18.8%) had a history of atopy. Fifteen patients (93.8%) were positive to the exercise provocation test. Nonsedating antihistamine drugs were a main treatment (73.8%). Six patients (37.5%) were in remission at the time of the study, with a mean duration 4.3 years. The Kaplan-Meier survival analysis demonstrated that 12.5%, 35.5%, and 67.9% of patients would have disease remission within 1 year, 5 years, and 13 years, respectively.
Conclusions: The prevalence of CholU differs in each geographic region and is found to be low in tropical countries with a median duration 4.3 years. The prevalence of atopy and anaphylaxis with CholU is also lower in tropical countries than in temperate.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273400 | PMC |
| http://dx.doi.org/10.1155/2020/7301652 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative Efficacy of Mometasone Nasal Spray Combined with Different Doses of Desloratadine, and Montelukast in Childhood Allergic Rhinitis: A Randomized Clinical Trial.
Iran J Allergy Asthma Immunol
July 2024
Division of Allergy and Clinical Immunology, Department of Pediatrics, Bahrami Children's Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- Allergic rhinitis is a common issue in children, and while several medications like nasal corticosteroids and antihistamines are used to treat it, there's ongoing debate about the best dosage and combinations for maximum effectiveness.* -
- A study involving 64 children compared the effects of different drug combinations alongside mometasone furoate nasal spray, measuring symptoms like nasal congestion and sneezing.* -
- Results showed that using desloratadine twice daily or a combination of desloratadine and montelukast significantly improved symptom control compared to other treatment options.*
Key differences between chronic inducible and spontaneous urticaria.
Front Allergy
October 2024
Division of Allergy, University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
Introduction: The latest international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for urticaria recommends limited laboratory testing for chronic spontaneous urticaria (CSU) and selective testing for only certain chronic inducible urticaria (CIndU) subtypes, though the rationale for these recommendations is poorly explained. This study aimed to improve the understanding of CIndU subtypes by comprehensively comparing their demographic, clinical, and laboratory characteristics with those of the better-characterized CSU.
Methods: We conducted a retrospective analysis of 567 patients (median age 41 years, 67% female) diagnosed with CSU, symptomatic dermographism (SD), cold urticaria (ColdU), cholinergic urticaria (CholU), and delayed pressure urticaria (DPU).
Decoding the variability in clinical and laboratory profiles of Chronic Inducible Urticaria vs. Chronic Spontaneous Urticaria - a retrospective study from a tertiary care center.
Arch Dermatol Res
October 2024
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Sector12, Chandigarh, 160012, India.
Article Synopsis
- Chronic inducible urticaria (CIndU) lasts longer than 6 weeks and is triggered by specific factors, but research on its severity and treatment is limited compared to chronic spontaneous urticaria (CSU).
- A study reviewed data from 222 CIndU patients and 226 CSU controls, finding that both groups were similar in age and gender, but CIndU patients had significantly lower CRP levels and a poorer quality of life score (CU-QOL).
- CIndU patients required more frequent antihistamine adjustments (80% vs. 52% in CSU) and took longer to achieve remission, averaging 60 days compared to 27.77 days for CSU patients.
Validation of the Cholinergic Urticaria Activity Score (CholUAS).
J Allergy Clin Immunol Pract
October 2024
Institute for Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany; Department of Dermatology and Allergology, Comprehensive Allergy Center, Kepler University Hospital, Linz, Austria; Medical Faculty, Johannes Kepler University, Linz, Austria. Electronic address:
Background: In cholinergic urticaria (CholU), itchy wheal and flare-type skin reactions are triggered by sweat-inducing activities. The CholU activity score (CholUAS) is used to assess disease activity but has not yet been validated. The aim of the study was to validate the CholUAS, develop an English version, and provide instructions for scoring.
View Article and Find Full Text PDFUnraveling the causative connection between urticaria, inflammatory cytokines, and mental disorders: Perspectives from genetic evidence.
Skin Res Technol
September 2024
Development and Regeneration Key Laboratory of Sichuan Province, Institute of Neuroscience, Department of Pathology and Pathophysiology, Chengdu Medical College, Chengdu, China.
Article Synopsis
- The study investigates the link between urticaria (a skin condition) and mental disorders, confirming that individuals with urticaria are at a higher risk for conditions like ADHD and schizophrenia.
- Using data from various genome studies, researchers found that different types of urticaria are associated with specific mental health risks and examined the role of inflammatory cytokines.
- The findings suggest that inflammatory cytokines do not mediate the relationship between urticaria and mental disorders, indicating a need for integrated treatment approaches that consider both physical and mental health.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!